Skip to main content
Premium Trial:

Request an Annual Quote

Mapmygenome Partners With Blockchain Startup Digital DNAtix

NEW YORK (GenomeWeb) – Indian consumer genomics company Mapmygenome is partnering with blockchain genetics startup Digital DNAtix to provide extra security and privacy for its direct-to-consumer genetic tests. The blockchain technology also will allow researchers to access anonymous data for their work, the companies said.

Digital DNAtix, of Ramat Gan, Israel, will provide Mapmygenome with a platform to offer its genome testing, analysis, and related personalized medicine services in a faster, more secure environment than previously available.

"Anyone can anonymously upload partial and/or full genome sequences onto the DNAtix platform, and then have access to to their genomic data which they can use to make informed decisions," Digital DNAtix CEO Ofer Lidsky said in a statement.

"It opens doors to a much larger audience base, and adds another layer of security with the promise of blockchain in addition to our secure lab information management systems," added Anu Acharya, CEO of Hyderabad, India-based Mapmygenome. "By utilizing DNAtix's blockchain-based platform for furthering the availability and accessibility to genomic services globally, we are taking yet another step towards empowering the masses with the promise of personal genomics — a doorway to preventive, predictive, personalized, precise medicine."

Mapmygenome, which launched in 2013, raised $1.1 million in an early financing round in 2015. The company reportedly raised an additional $20 million in 2016. 

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.